188 related articles for article (PubMed ID: 33273987)
1. Clinicopathological and Prognostic Significance of CBX3 Expression in Human Cancer: a Systematic Review and Meta-analysis.
Lin H; Zhao X; Xia L; Lian J; You J
Dis Markers; 2020; 2020():2412741. PubMed ID: 33273987
[TBL] [Abstract][Full Text] [Related]
2. CBX3 promotes tumor proliferation by regulating G1/S phase via p21 downregulation and associates with poor prognosis in tongue squamous cell carcinoma.
Zhang H; Chen W; Fu X; Su X; Yang A
Gene; 2018 May; 654():49-56. PubMed ID: 29462646
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.
Zhang J; Gu Y; Liu X; Rao X; Huang G; Ouyang Y
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32696952
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and clinicopathological significance of MicroRNA-153 in human cancers: A meta-analysis.
Huang M; Li C; Kong F; Wu Y; Yuan Q; Hu L
Medicine (Baltimore); 2020 Nov; 99(46):e22833. PubMed ID: 33181653
[TBL] [Abstract][Full Text] [Related]
6. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
[TBL] [Abstract][Full Text] [Related]
8. Association between Alpha B-crystallin expression and prognosis in patients with solid tumors: A protocol for systematic review and meta-analysis.
Yang M; Li Y; Tian F
Medicine (Baltimore); 2021 Feb; 100(7):e24831. PubMed ID: 33607849
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
Zhang S; Qiu D; Xie X; Shen Y
BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.
Luo Z; Wu RR; Lv L; Li P; Zhang LY; Hao QL; Li W
Int J Clin Exp Pathol; 2014; 7(7):3632-46. PubMed ID: 25120740
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and clinicopathological significance of miR-638 in cancer patients: A meta-analysis.
Hu L; Huang M; Yuan Q; Kong F
Medicine (Baltimore); 2021 Apr; 100(15):e25441. PubMed ID: 33847647
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and clinicopathological significance of kinesin family member C1 in various cancers: A meta-analysis.
Sun Y; Zhang Y; Lang Z; Huang J; Zou Z
Medicine (Baltimore); 2019 Oct; 98(40):e17346. PubMed ID: 31577729
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and clinicopathological significance of CapG in various cancers: Evidence from a meta-analysis.
Lang Z; Chen Y; Zhu H; Sun Y; Zhang H; Huang J; Zou Z
Pathol Res Pract; 2019 Dec; 215(12):152683. PubMed ID: 31685300
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic role of ROC1 in neoplasms: A PRISMA-compliant systematic review and meta-analysis.
Shen N; Wang Q; Qiu Y; Wang Y; Li D; Li M
Medicine (Baltimore); 2022 Jul; 101(26):e29806. PubMed ID: 35777041
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of HHLA2 expression in solid tumors: A meta-analysis based on the Chinese population.
Zhang C; Xu J; Ye J; Zhang X
Medicine (Baltimore); 2021 Jul; 100(30):e26789. PubMed ID: 34397730
[TBL] [Abstract][Full Text] [Related]
16. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
[TBL] [Abstract][Full Text] [Related]
17. Metastasis-associated protein 1 as a new prognostic marker for solid tumors: a meta-analysis of cohort studies.
Luo H; Li H; Yao N; Hu L; He T
Tumour Biol; 2014 Jun; 35(6):5823-32. PubMed ID: 24599674
[TBL] [Abstract][Full Text] [Related]
18. CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
Ma C; Nie XG; Wang YL; Liu XH; Liang X; Zhou QL; Wu DP
Mol Med Rep; 2019 May; 19(5):4205-4212. PubMed ID: 30942427
[TBL] [Abstract][Full Text] [Related]
19. CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma.
Zhong X; Kan A; Zhang W; Zhou J; Zhang H; Chen J; Tang S
Aging (Albany NY); 2019 Aug; 11(15):5483-5497. PubMed ID: 31375643
[TBL] [Abstract][Full Text] [Related]
20. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
Zhang B; Xie Z; Li B
Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]